10 research outputs found

    Canine Crackdown: Unreliable Drug Sniffs Threaten Civil Liberties and Equal Law Enforcement

    No full text
    This paper explores the history of drug detection dogs in law enforcement, critically examines their ability to successfully detect illicit substances, and investigates the legal repercussions of dog alerts in the field. While drug dog programs have experienced substantial success in the U.S. with annual drug seizures valued between 2and2 and 3 billion, experiments on police-trained dogs have shown that though canines have incredible sensitivity in controlled settings, other factors including the breed of the dog, handler bias, and even the race of the suspect have been shown to significantly reduce a dog’s detection accuracy. These reports raise serious questions about the efficacy of drug detecting dogs, and if a dog alert should generate probable cause for a search or seizure of property that is otherwise protected under the Fourth Amendment. In particular, the threat of racial discriminatory practices raises the concern that dogs can be used to inappropriately extend law enforcement authority against ethnic minorities. Though these canines must complete a rigorous training course in order to search for narcotics, police are not required to keep careful records of their dogs’ performances on drug detection. As exemplified by a successful investigation and the subsequent removal of the ineffective drug detection dog program in New South Wales, this article calls the U.S. to similarly investigate the accuracy of its drug sniffs in order to protect its citizens from seemingly unreliable dog alerts and the warantless searches and seizures that follow

    Beyond the Cell Surface: Targeting Intracellular Negative Regulators to Enhance T cell Anti-Tumor Activity

    No full text
    It is well established that extracellular proteins that negatively regulate T cell function, such as Cytotoxic T-Lymphocyte-Associated protein 4 (CTLA-4) and Programmed Cell Death protein 1 (PD-1), can be effectively targeted to enhance cancer immunotherapies and Chimeric Antigen Receptor T cells (CAR-T cells). Intracellular proteins that inhibit T cell receptor (TCR) signal transduction, though less well studied, are also potentially useful therapeutic targets to enhance T cell activity against tumor. Four major classes of enzymes that attenuate TCR signaling include E3 ubiquitin kinases such as the Casitas B-lineage lymphoma proteins (Cbl-b and c-Cbl), and Itchy (Itch), inhibitory tyrosine phosphatases, such as Src homology region 2 domain-containing phosphatases (SHP-1 and SHP-2), inhibitory protein kinases, such as C-terminal Src kinase (Csk), and inhibitory lipid kinases such as Src homology 2 (SH2) domain-containing inositol polyphosphate 5-phosphatase (SHIP) and Diacylglycerol kinases (DGKs). This review describes the mechanism of action of eighteen intracellular inhibitory regulatory proteins in T cells within these four classes, and assesses their potential value as clinical targets to enhance the anti-tumor activity of endogenous T cells and CAR-T cells

    Cytokines and the pathogenesis of atherosclerosis

    No full text

    Bibliography on Dictyostelium

    No full text

    Listing of Protein Spectra

    No full text
    corecore